The state of CD44 activation in cancer progression and therapeutic targeting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The state of CD44 activation in cancer progression and therapeutic targeting
Authors
Keywords
-
Journal
FEBS Journal
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-04
DOI
10.1111/febs.16179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation
- (2020) Madoka Kawaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD44 as a tumor biomarker and therapeutic target
- (2020) Hanxiao Xu et al. Experimental Hematology & Oncology
- CD44v6 engages in colorectal cancer progression
- (2019) Lixin Ma et al. Cell Death & Disease
- Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44
- (2019) Alice Spadea et al. MOLECULAR PHARMACEUTICS
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
- (2018) Yaqi Lv et al. ACS Nano
- Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
- (2018) Yuanyuan Liu et al. Acta Biomaterialia
- Molecular weight impact on the mechanical forces between hyaluronan and its receptor
- (2018) Lei Jiang et al. CARBOHYDRATE POLYMERS
- Parallel Accumulation of Tumor Hyaluronan, Collagen and Other Drivers of Tumor Progression
- (2018) Xiaoming Li et al. CLINICAL CANCER RESEARCH
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment
- (2018) Yuzhou Shen et al. Drug Design Development and Therapy
- Cancer stem cells (CSCs) in cancer progression and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
- (2018) Xia Liu et al. Cancer Discovery
- Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance
- (2018) Zoe Price et al. Cancers
- Exploring the relationship of hyaluronic acid molecular weight and active targeting efficiency for designing hyaluronic acid-modified nanoparticles
- (2018) Lu Zhong et al. Asian Journal of Pharmaceutical Sciences
- The survival of fetal and bone marrow monocyte-derived alveolar macrophages is promoted by CD44 and its interaction with hyaluronan
- (2017) Y Dong et al. Mucosal Immunology
- Understanding the role of CD44V6 in ovarian cancer
- (2017) Hui-Feng Zhang et al. Oncology Letters
- Impact of structurally modifying hyaluronic acid on CD44 interaction
- (2017) D. S. Bhattacharya et al. Journal of Materials Chemistry B
- CD44: More than a mere stem cell marker
- (2016) I. Morath et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
- (2016) Hanxiao Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells
- (2015) Hai Wang et al. BIOMATERIALS
- Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin
- (2015) Roshan Pradhan et al. CARBOHYDRATE POLYMERS
- CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells
- (2015) KeeSoo Nam et al. CELLULAR SIGNALLING
- Nanocarriers for cancer-targeted drug delivery
- (2015) Preeti Kumari et al. JOURNAL OF DRUG TARGETING
- Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
- (2015) George Mattheolabakis et al. JOURNAL OF DRUG TARGETING
- Mechanical force effect on the two-state equilibrium of the hyaluronan-binding domain of CD44 in cell rolling
- (2015) Takashi Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
- (2015) Yan Gao et al. Oncotarget
- Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
- (2015) Cuixia Yang et al. Oncotarget
- Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells
- (2015) Hongxin Shen et al. Theranostics
- CD44variant exon 9 plays an important role in colon cancer initiating cells
- (2015) Youhei Kimura et al. Oncotarget
- CD44 clustering is involved in monocyte differentiation
- (2014) Guoliang Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging
- (2014) Jingchao Li et al. BIOMATERIALS
- CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
- (2014) W. M. Lau et al. CANCER RESEARCH
- Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
- (2014) Alexander Pietras et al. Cell Stem Cell
- Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
- (2014) Y. Xu et al. GENES & DEVELOPMENT
- Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset
- (2014) M. Veiseh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- Hyaluronan, a Crucial Regulator of Inflammation
- (2014) Aaron C. Petrey et al. Frontiers in Immunology
- Hyaluronan-CD44 Interaction Promotes Growth of Decidual Stromal Cells in Human First-Trimester Pregnancy
- (2013) Rui Zhu et al. PLoS One
- Distinct Kinetic and Molecular Requirements Govern CD44 Binding to Hyaluronan versus Fibrin(ogen)
- (2012) Phrabha S. Raman et al. BIOPHYSICAL JOURNAL
- Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma
- (2012) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering
- (2012) Cuixia Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma
- (2012) Takeshi Hanagiri et al. TUMOR BIOLOGY
- Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel
- (2011) Hyun-Jong Cho et al. BIOMATERIALS
- Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers
- (2011) Gideon Bachar et al. BIOMATERIALS
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
- (2011) Shoshy Mizrahy et al. JOURNAL OF CONTROLLED RELEASE
- Understanding the Dual Nature of CD44 in Breast Cancer Progression
- (2011) J. M. V. Louderbough et al. MOLECULAR CANCER RESEARCH
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
- (2011) L Y W Bourguignon et al. ONCOGENE
- Hyaluronan in human malignancies
- (2010) R.K. Sironen et al. EXPERIMENTAL CELL RESEARCH
- Analysis of CD44-Hyaluronan Interactions in an Artificial Membrane System
- (2010) Patricia M. Wolny et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of the Phosphatidylinositol-3-Kinase Pathway Abrogates Polyinosinic:Polycytidylic Acid–Stimulated Hyaluronan-Mediated Human Mucosal Smooth Muscle Cell Binding of U937 Monocytic Cells
- (2010) Sudip K. Bandyopadhyay et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Two-State Conformations in the Hyaluronan-Binding Domain Regulate CD44 Adhesiveness under Flow Condition
- (2010) Shinji Ogino et al. STRUCTURE
- Self-assembled hyaluronic acid nanoparticles for active tumor targeting
- (2009) Ki Young Choi et al. BIOMATERIALS
- Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
- (2009) B. P. Toole CLINICAL CANCER RESEARCH
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
- (2009) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
- (2009) Claude C. Warzecha et al. MOLECULAR CELL
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
- (2009) Mo Chen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression
- (2008) Naoki Itano et al. CANCER SCIENCE
- CD44 is of Functional Importance for Colorectal Cancer Stem Cells
- (2008) L. Du et al. CLINICAL CANCER RESEARCH
- Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
- (2008) Bryan P. Toole et al. DRUG RESISTANCE UPDATES
- Differential Activation of ERK and Rac Mediates the Proliferative and Anti-proliferative Effects of Hyaluronan and CD44
- (2008) Devashish Kothapalli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xLGene Expression and Chemoresistance in Breast Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD44 promotes progenitor homing into the thymus and T cell maturation
- (2008) M. Rajasagi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
- (2008) Herbert Riechelmann et al. ORAL ONCOLOGY
- Altered hyaluronan biosynthesis in cancer progression
- (2008) Naoki Itano et al. SEMINARS IN CANCER BIOLOGY
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
- (2008) Lilly Y.W. Bourguignon SEMINARS IN CANCER BIOLOGY
- Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan
- (2008) Raija H. Tammi et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started